Independent peptide research, reference & news No clinic, pharmacy, or telehealth affiliation
Subscribe
Bioregulators Preliminary

Pinealon

Peptide bioregulator

Also known as: Glu-Asp-Arg

Written and reviewed by the Peptide.it editorial team Last reviewed June 2026 · Every claim is tier-rated and sourced

In plain language

Pinealon is a short synthetic peptide (three amino acids) marketed as a bioregulator aimed at the brain and nervous system. The supporting research is mostly small and from a single group, so the human evidence is weak and has not been independently confirmed.

What it is explored for

Pinealon comes from the bioregulator tradition, where short peptides are explored for gentle, whole-body support as we age. It draws curiosity for its reported links to sleep, clear thinking, and antioxidant defense, though the research remains early and unconfirmed.

  • Sleep quality and restful nights
  • Focus, memory, and mental clarity
  • Brain resilience and neuroprotection
  • Antioxidant and healthy-aging support
  • Balanced circadian rhythm
  • Mood and overall well-being

These are areas of active interest and reported use, not proven outcomes. This peptide carries a preliminary rating, see the evidence summary below for how strong the science actually is.

How it works

Pinealon is described by its developers as a peptide bioregulator intended to support brain cells. The proposed mechanisms come largely from one research group and are not broadly established.

  • Proposed neuroprotection. Cell and animal reports describe protection of neurons against oxidative stress, but these studies are small and largely from the originating group.
  • Proposed gene regulation. Developers suggest the peptide can enter cells and influence gene expression, a hypothesis not widely replicated independently.

These mechanisms are preliminary findings from mostly single-source laboratory research and are not established in humans.

Evidence summary

Evidence for Pinealon comes mainly from cell and animal studies, largely from the developing group, with little independent replication. There are no large, well-controlled human trials, so any cognitive or neuroprotective benefits remain unproven.

Reported safety & side effects

Human safety data are very limited. Long-term effects, interactions, and risks in people are not established because rigorous trials are lacking.

Human safety dataVery limited; no large controlled trials
Regulatory statusNot FDA-approved; research use only
Long-term effectsUnknown

Frequently asked

Is Pinealon FDA-approved?

No. Pinealon is not approved by the FDA. In some regions it is sold as a supplement, but it is not an approved medicine.

Does it improve memory or protect the brain?

That is unproven in people. Most evidence is from cell and animal studies by one group, with little independent replication, so cognitive benefits are not established.